Alzheimer’s disease
Can boosting sleep help to tackle tau?
Researchers are investigating whether enhancing sleep can slow the build-up of a key Alzheimer’s protein
Investigating individual brain cell responses to disease
Researchers at University College London will study how brains are affected by prion diseases using cutting edge technology to look at individual cells
Investigating lithium in Alzheimer’s disease using brain imaging
Researchers at the University of Newcastle will study whether lithium could be a future treatment for Alzheimer’s disease using a new brain imaging technique
World’s largest study of spatial navigation offers free study platform to researchers
The groundbreaking citizen science app Sea Hero Quest is now available for studies of cognition and spatial navigation
No increased dementia risk after hormone replacement therap
New research has found no link between hormone replacement therapy and dementia risk, however those receiving oestrogen-progesterone therapy for over five years were found to have a small increased risk of Alzheimer’s disease. The BMJ have published the research today (Wednesday 29 September). What is HRT? Hormone replacement therapy (HRT) is commonly offered to help…
Diabetes drug may reduce dementia risk, new study suggests
New research that patients with Alzheimer’s disease taking a class of drugs known as gliptins have lower levels of the hallmark Alzheimer’s protein in their brains. They also had better scores on memory and thinking tests years after the beginning of the study compared to those not on the drug or those who didn’t have diabetes.
Difficulty hearing speech could be a risk factor for dementia
Research links the cocktail party problem with an increased risk of dementia in a study conducted at the University of Oxford. Alzheimer’s Research UK comments on the findings.
Gut-brain axis important in creation of new brain cells
Researchers at the UK Dementia Research Institute find that the contents are the gut are important for the creation of new brain cells.
When could aducanumab reach the UK?
Today is a historic day for dementia research with the US Food and Drug Administration (FDA) announcing the first (conditional) licence of a new drug for Alzheimer’s disease in a generation.
Understanding the relationship between iron and dementia
Researchers at the University of Oxford are investigating how iron levels can be used as a marker for dementia.
